EUROPEAN JOURNAL OF
CLINICAL PHARMACOLOGY
Volume 60 Number 4 June 2004
Special Article
Stichtenoth DO, Frolich JC:
Pregraduate teaching clinical pharmacology
in Germany 225
Pha rmacogenetics
Eap CB, Buclin T, Hustert E, Bleiber G, Golay KP, Aubert A-C, Baumann P, Telenti A, Kerb R: Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects 231
Eap CB, Buclin T, Cucchia G, Zullino D,
Hustert E, Bleiber G, Golay KP, Aubert A-C,
Baumann P, Telenti A, Kerb R:
Oral administration of a low dose
of midazolam (75 |ig) as an in vivo probe
for CYP3A activity 237
Pharmacokinetics and Disposition
Sobue S, Tan K, Shaw L, Layton G,
Must R;
Comparison of the pharmacokinetics
of fosfluconazole and fluconazole after
single intravenous administration
of fosfluconazole in healthy Japanese
and Caucasian volunteers 247
NagashimaS, Niwa M, Nishiki K, HosoyaT, HishidaA, UematsuT: Effects of SCH27899 (Ziracin), an oligo-saccharide everninomicin antibiotic, on urate kinetics in humans 255
Daley-Yates PT, Kunka RL, Yin Y, Andrews SM, Callejas S, Ng C: Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays 265
Na-Bangchang K, Doua F, Konsil J, Hanpitakpong W, Kamanikom B, Kuzoe F: The pharmacokinetics of eflornithine (a-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness 269
Pharmacoepidemiology and Prescription
Clinard F, Sgro C, Bardou M. Hilton P, Dumas M, Kreft-Jais C, Escousse A, Bonithon-Kopp C:
Association between concomitant use of several systemic NSAIDs and an excess risk of adverse drug reaction. A case/non-case study from the French Pharmacovigilance system database 279
Dugue A, Bagheri H, Lapeyre-Mestre M, Tournamille JF, Sailler L, Dedieu G, Salvayre R, Thouvenot JP, Massip P, Montastruc JL:
Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals 285
Letters to the Editors
Marchetti F, Ronfani L, Conti Nibali S, Bonati M, Tamburlini G: Restricted indications for the use of antibiotics in acute otitis media 293
Carrillo JA, Gonzalez JA, Gervasini G, Lopez R, Fernandez MA, Nunez GM: Thrombocytopenia and fatality associated with olanzapine 295
Clarification
297
Anderson BJ, Holford NHG: No urine, no urinary clearance
Forthcoming articles in print published online and citable with the DOI (Digital Object Identifier) can be found atspringerlink.com
Indexed in/abstracted by Current Contents and Index Medicus
New: Electronic submission http://ejcp.manuscriptcentral.com